首页> 外文期刊>Cureus. >Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: A Treatment Planning Study
【24h】

Stereotactic Arrhythmia Radioablation (STAR) of Ventricular Tachycardia: A Treatment Planning Study

机译:室性心动过速的立体定向性心律不齐消融(STAR):治疗计划研究

获取原文
           

摘要

Purpose The first stereotactic arrhythmia radioablation (STAR) of ventricular tachycardia (VT) was delivered at Stanford on a robotic radiosurgery system (CyberKnife? G4) in 2012. The results warranted further investigation of this treatment. Here we compare dosimetrically three possible treatment delivery platforms for STAR. Methods The anatomy and target volume of the first treated patient were used for this study. A dose of 25 Gy in one fraction was prescribed to the planning target volume (PTV). Treatment plans were created on three treatment platforms: CyberKnife? G4 system with Iris collimator (Multiplan, V. 4.6)(Plan #1), CyberKnife? M6 system with InCise 2supTM/sup multileaf collimator (Multiplan V. 5.3)(Plan #2) and Varian TrueBeamsupTM/sup STx with HD 120supTM/sup MLC and 10MV flattening filter free (FFF) beam (Eclipse planning system, V.11) (Plan #3 coplanar and #4 noncoplanar VMAT plans). The four plans were compared by prescription isodose line, plan conformity index, dose gradient, as well as dose to the nearby critical structures. To assess the delivery efficiency, planned monitor units (MU) and estimated treatment time were evaluated. Results Plans #1-4 delivered 25 Gy to the PTV to the 75.0%, 83.0%, 84.3%, and 84.9% isodose lines and with conformity indices of 1.19, 1.16, 1.05, and 1.05, respectively. The dose gradients for plans #1-4 were 3.62, 3.42, 3.93, and 3.73 with the CyberKnife? MLC plan (Plan #2) the best, and the TrueBeamsupTM/sup STx co-planar plan (Plan #3) the worst. The dose to nearby critical structures (lung, stomach, bowel, and esophagus) were all well within tolerance. The MUs for plans #1-4 were 27671, 16522, 6275, and 6004 for an estimated total-treatment-time/beam-delivery-time of 99/69, 65/35, 37/7, and 56/6 minutes, respectively, under the assumption of 30 minutes pretreatment setup time. For VMAT gated delivery, a 40% duty cycle, 2400MU/minute dose rate, and an extra 10 minutes per extra arc were assumed. Conclusion Clinically acceptable plans were created with all three platforms. Plans with MLC were considerably more efficient in MU. CyberKnife? M6 with InCise 2supTM/sup collimator provided the most conformal plan (steepest dose drop-off) with significantly reduced MU and treatment time. VMAT plans were most efficient in MU and delivery time. Fluoroscopic image guidance removes the need for additional fiducial marker placement; however, benefits may be moderated by worse dose gradient and more operator-dependent motion management by gated delivery.
机译:目的于2012年在斯坦福大学通过机器人放射外科手术系统(Cyber​​Knife?G4)交付了首例室性心动过速(VT)的立体定向心律不齐消融术(STAR)。结果值得对该方法进行进一步的研究。在这里,我们在剂量学上比较STAR的三种可能的治疗提供平台。方法采用第一位接受治疗的患者的解剖结构和目标体积。计划目标体积(PTV)的剂量为一小部分25 Gy。在三个治疗平台上创建了治疗计划:射波刀?使用虹膜准直仪的G4系统(Multiplan,V。4.6)(计划1),Cyber​​Knife?带有InCise 2 TM 多叶准直仪(Multiplan V.5.3)(计划2)和Varian TrueBeam TM STx的M6系统以及HD 120 TM MLC和10MV平坦化无滤波器(FFF)光束(Eclipse规划系统,V.11)(#3共面计划和#4非共面VMAT计划)。通过处方等剂量线,计划合格指数,剂量梯度以及附近关键结构的剂量比较了这四个计划。为了评估输送效率,评估了计划的监测单位(MU)和估计的治疗时间。结果1-4号计划将25 Gy的Pod输送到PTV的等剂量线为75.0%,83.0%,84.3%和84.9%,其合格指数分别为1.19、1.16、1.05和1.05。计划#1-4中使用“射波刀”的剂量梯度分别为3.62、3.42、3.93和3.73。 MLC计划(计划2)最好,而TrueBeam TM STx共平面计划(计划3)最差。对附近关键结构(肺,胃,肠和食道)的剂量均在耐受范围之内。计划1-4的MU为27671、16522、6275和6004,估计总治疗时间/束交付时间为99 / 69、65 / 35、37 / 7和56/6分钟,分别假设30分钟的预处理建立时间。对于VMAT门控传送,假定占空比为40%,剂量率为2400MU /分钟,每增加一弧,则需要额外的10分钟。结论使用这三个平台均创建了临床可接受的计划。使用MLC的计划在MU中效率更高。射波刀?带有InCise 2 TM 准直仪的M6提供了最适形的计划(最陡峭的剂量下降),同时显着减少了MU和治疗时间。 VMAT计划在MU和交付时间方面最有效。透视图像引导无需额外的基准标记放置;但是,由于剂量梯度变差以及门控式输送增加了更多的操作员依赖性运动管理,可能会降低收益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号